What it sells
Medical nebulised drug delivery.
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospitals, distributors and brand partners ordering OEM/ODM nebulizers (inferred from customized service pages).
Trigger: what makes them buy now?
UnverifiedBrand owners or distributors needing certified (CE, FDA, ISO13485) nebulizers made to their own spec for respiratory care lines.
Workflow: what inputs become what output?
Develops particle-size (aerodynamic diameter) and lung-deposition nebulization technology, then manufactures under ISO13485 with customized capacity and quality control.
Economics: what it saves and how it charges
Hardware manufacturing plus customized OEM/ODM service; company cites 100+ staff, 4000 sqm R&D base and 50+ patents.
Distribution: how it reaches customers
UnverifiedExport-oriented, multi-language site (English, Chinese, Spanish, Portuguese, Arabic); sold through contact/enquiry, no online store seen.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-09-23 | Series B | 5000万元 | — | news.pedaily.cn |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.